0001209191-23-043826.txt : 20230731 0001209191-23-043826.hdr.sgml : 20230731 20230731162814 ACCESSION NUMBER: 0001209191-23-043826 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230731 DATE AS OF CHANGE: 20230731 EFFECTIVENESS DATE: 20230731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-488378 FILM NUMBER: 231127715 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 D 1 primary_doc.xml X0708 D LIVE 0001183765 Molecular Templates, Inc. 9301 Amberglen Blvd Suite 100 Austin TX TEXAS 78729 512-869-1555 DELAWARE Threshold Pharmaceuticals, Inc. THRESHOLD PHARMACEUTICALS INC Corporation true Eric E. Poma c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Executive Officer Director Harold E. Selick c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Director Gabriela Gruia c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Director David Hoffmann c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Director Kevin Lalande c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Director Jonathan Lanfear c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Director Corsee Sanders c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Director Jason Kim c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Executive Officer Roger J. Waltzman c/o Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin TX TEXAS 78729 Executive Officer Biotechnology Decline to Disclose 06b false 2023-07-17 true true true true false 0 Stifel, Nicolaus & Company, Incorporated 793 None None 745 7th Avenue New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT MA MASSACHUSETTS NY NEW YORK 90738000 19999998 70738002 Total offering amount includes the $0.125 per underlying share of common stock for warrants to purchase common stock to be issued in a second closing, assuming certain conditions are met, and the aggregate exercise price of such warrants. false 19 2700000 true 0 0 false Molecular Templates, Inc. /s/ Eric E. Poma, Ph.D. Eric E. Poma, Ph.D. Chief Executive Officer 2023-07-26